Page 103 - FINAL PROGRAMME 2017

TUESDAY, 4 JULY 2017
SELECTED ORAL COMMUNICATIONS
10:00 - 11:30 Room A
Session 34: Drugs and protocols in ART
Chairman: E. Kolibianakis (Greece) Chairman: B. Imthurn (Switzerland)
10:00 O-116
10:15 O-117
Submaximal doses of ghrelin do not inhibit gonadotrophin levels but stimulate prolactin secretion in postmenopausal women
C.I. Messini1, M. Malandri1, G. Anifandis1, K. Dafopoulos1, P. Georgoulias2, A. Garas1, A. Daponte1, I.E. Messinis1
1University of Thessaly- School of Health Sciences- Faculty of Medicine, Department of Obstetrics and Gynaecology, Larissa, Greece
2University of Thessaly- School of Health Sciences- Faculty of Medicine, Department of Nuclear Medicine, Larissa, Greece
A second dose of kisspeptin safely optimizes oocyte maturation in women undergoing in IVF treatment: a phase 2 randomized controlled trial
A. Abbara1, S. Clarke1, R. Islam2, J. Prague1, A. Comninos1, S. Narayanaswamy1, D. Papadopoulou1, R. Roberts1, C. Izzi-Engbeaya1, R. Ratnasabapathy1, A. Nesbitt1, S. Vimalesvaran1, R. Salim2, S. Lavery2, S. Bloom1, L. Huson3, G. Trew2, W. Dhillo1
1Imperial College London, Section of Investigative Medicine, London, United Kingdom 2Imperial College NHS Trust, IVF medicine, London, United Kingdom
3Imperial College London, Division of Experimental Medicine, London, United Kingdom
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 103
SCIENTIFIC PROGRAMME TUESDAY, 4 JULY